Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.12, 2003-01, pp. : 885-912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

By Curran Monique P. Keating Gillian M.

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 2009-2035

Adis International

Access to resources Recommend Favorite

Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

By Goa K.L. Noble S.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 439-462

Adis International

Access to resources Recommend Favorite

Therapeutic Use of Intravenous Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention: Acute Coronary Syndromes and Elective Stenting

By Juan F. Granada Neal S. Kleiman

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 31-41

Adis International

Access to resources Recommend Favorite

Prasugrel: A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

By Duggan Sean T. Keating Gillian M.

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1707-1726

Adis International

Access to resources Recommend Favorite

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

By Jennings Lisa K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 727-737

Informa Healthcare

Access to resources Recommend Favorite